Immune and Gene Therapy as an Emerging Cancer Treatment

Kenzaburo Tani(Tokyo Medical University), Toshihiko Okazaki(Johns Hopkins University), Kazunari Yamada(Kyushu University Hospital), Mutsunori Murahashi(Jikei University School of Medicine), Yoshihiro Tanaka(Kyushu University Hospital), Hiroyuki Inoue(Fukuoka University), Shohei Miyamoto(Kyushu University), Yasuki Hijikata(Kyushu University Hospital), Toshihisa Tsuruta(Nagoya University Hospital), Shinichi Kobayashi(Aichi Prefectural Government)
Annals of Oncology
October 1, 2014
10.1093/annonc/mdu412.1
Cited by 0

Related Papers

Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis
|Human Molecular Genetics|2003|337
The long-term survival of stage IV gastric cancer patients with conversion therapy
|Gastric Cancer|2017|168
Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset ( <i>Callithrix jacchus</i> )
|Stem Cells|2005|155
Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)
|Blood|1994|147
Mice lacking a transcriptional corepressor Tob are predisposed to cancer
|Genes & Development|2003|123